Adragos Pharma has acquired Sanofi’s Maisons-Alfort sterile fill-finish site in France, expanding its European manufacturing network and prefilled syringe capabilities.
The acquisition marks Samsung Biologics’ geographical diversification, establishing its first US manufacturing presence and expanding regional client support.
As pharmaceutical production methods continue to evolve, flow chemistry is emerging as a safer, more scalable and selective alternative to conventional batch manufacturing.
Am Standort Worms bringt Röhm eine selbst entwickelte innovative Technologie erstmals im industriellen Maßstab zum Einsatz, die die Aufbereitung von chemisch recyceltem Methylmethacrylat (MMA) ermöglicht.
